Skip to main content
FinSpry Logo
FinSpry
MRKR logo
MRKR
(NASDAQ)
Marker Therapeutics, Inc.
$1.32-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Marker Therapeutics (MRKR) Stock Price & Financial Analysis

Marker Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.27 - $1.33
52-Week High$4.07
52-Week Low$0.81
Open$1.30
Volume93.95K
Average Volume (3M)93.95K
Market Cap22.12M
Shares Outstanding16.76M
Price to Sales (P/S)4.68
Price to Book (P/B)1.19
EV/EBITDA-0.30
Revenue (TTM)4.69M
Net Income (TTM)-14.30M
Free Cash Flow (TTM)-14.82M
EPS (TTM)$-0.85
Profit Margin-304.54%
Operating Margin-307.02%
Return on Equity (ROE)-77.75%
Debt to Equity0.00
50-Day MA$1.51
200-Day MA$1.32
52-Week Change14.91%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Marker Therapeutics

What is the current stock price for MRKR?

As of the latest trading session, MRKR stock trades at $1.32. The 52-week range is $0.81–$4.07, with a day range of $1.27–$1.33.

What is the P/E ratio for MRKR?

The P/E ratio (Price-to-Earnings) for MRKR is shown in the Key Statistics section. This valuation metric helps compare Marker Therapeutics, Inc. to industry peers.

Does MRKR pay dividends?

Marker Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MRKR?

Analyst ratings and recommendations for MRKR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of MRKR?

Marker Therapeutics's market capitalization is $22.1M, classifying it as a micro-cap company. Marker Therapeutics operates in the Healthcare sector within the Biotechnology industry.